Selected research
Industry Research
Engineered Bacterial Cell Protein Industry Research Report 2026
Market perspective
The global Engineered Bacterial Cell Protein market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Engineered Bacterial Cell Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Engineered Bacterial Cell Protein is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Engineered Bacterial Cell Protein is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Engineered Bacterial Cell Protein include Calysta, Shougang Lanza Tech, Air Protein (Kiverdi), ICell Sustainable Nutrition, String Bio, Unibio, Arbiom, NovoNutrients and Superbrewed Food, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Engineered Bacterial Cell Protein market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Engineered Bacterial Cell Protein Market by Company
Calysta
Shougang Lanza Tech
Air Protein (Kiverdi)
ICell Sustainable Nutrition
String Bio
Unibio
Arbiom
NovoNutrients
Superbrewed Food
Solar Foods
Bond Pet Foods
Engineered Bacterial Cell Protein Segment by Type
Industrial Waste as Raw Material
Transform Engineering bacteria as Raw Material
Others
Engineered Bacterial Cell Protein Segment by Application
Food
Feed
Others
Engineered Bacterial Cell Protein Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Engineered Bacterial Cell Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Engineered Bacterial Cell Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Engineered Bacterial Cell Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Engineered Bacterial Cell Protein manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Engineered Bacterial Cell Protein by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Engineered Bacterial Cell Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Industrial Waste as Raw Material
- Transform Engineering bacteria as Raw Material
- Others
Applications
- Food
- Feed
- Others
Companies covered
- Calysta
- Shougang Lanza Tech
- Air Protein (Kiverdi)
- ICell Sustainable Nutrition
- String Bio
- Unibio
- Arbiom
- NovoNutrients
- Superbrewed Food
- Solar Foods
- Bond Pet Foods
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Engineered Bacterial Cell Protein Market Size (2021-2032)
- 2.2.2 Global Engineered Bacterial Cell Protein Sales (2021-2032)
- 2.2.3 Global Engineered Bacterial Cell Protein Market Average Price (2021-2032)
- 2.3 Engineered Bacterial Cell Protein by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Industrial Waste as Raw Material
- 2.3.3 Transform Engineering bacteria as Raw Material
- 2.3.4 Others
- 2.4 Engineered Bacterial Cell Protein by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Food
- 2.4.3 Feed
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Engineered Bacterial Cell Protein Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Engineered Bacterial Cell Protein Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Engineered Bacterial Cell Protein Revenue of Manufacturers (2021-2026)
- 3.4 Global Engineered Bacterial Cell Protein Average Price by Manufacturers (2021-2026)
- 3.5 Global Engineered Bacterial Cell Protein Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Engineered Bacterial Cell Protein, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Engineered Bacterial Cell Protein, Product Type & Application
- 3.8 Global Manufacturers of Engineered Bacterial Cell Protein, Established Date
- 3.9 Global Engineered Bacterial Cell Protein Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Calysta
- 4.1.1 Calysta Company Information
- 4.1.2 Calysta Business Overview
- 4.1.3 Calysta Engineered Bacterial Cell Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Calysta Engineered Bacterial Cell Protein Product Portfolio
- 4.1.5 Calysta Recent Developments
- 4.2 Shougang Lanza Tech
- 4.2.1 Shougang Lanza Tech Company Information
- 4.2.2 Shougang Lanza Tech Business Overview
- 4.2.3 Shougang Lanza Tech Engineered Bacterial Cell Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shougang Lanza Tech Engineered Bacterial Cell Protein Product Portfolio
- 4.2.5 Shougang Lanza Tech Recent Developments
- 4.3 Air Protein (Kiverdi)
- 4.3.1 Air Protein (Kiverdi) Company Information
- 4.3.2 Air Protein (Kiverdi) Business Overview
- 4.3.3 Air Protein (Kiverdi) Engineered Bacterial Cell Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Air Protein (Kiverdi) Engineered Bacterial Cell Protein Product Portfolio
- 4.3.5 Air Protein (Kiverdi) Recent Developments
- 4.4 ICell Sustainable Nutrition
- 4.4.1 ICell Sustainable Nutrition Company Information
- 4.4.2 ICell Sustainable Nutrition Business Overview
- 4.4.3 ICell Sustainable Nutrition Engineered Bacterial Cell Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 ICell Sustainable Nutrition Engineered Bacterial Cell Protein Product Portfolio
- 4.4.5 ICell Sustainable Nutrition Recent Developments
- 4.5 String Bio
- 4.5.1 String Bio Company Information
- 4.5.2 String Bio Business Overview
- 4.5.3 String Bio Engineered Bacterial Cell Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 String Bio Engineered Bacterial Cell Protein Product Portfolio
- 4.5.5 String Bio Recent Developments
- 4.6 Unibio
- 4.6.1 Unibio Company Information
- 4.6.2 Unibio Business Overview
- 4.6.3 Unibio Engineered Bacterial Cell Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Unibio Engineered Bacterial Cell Protein Product Portfolio
- 4.6.5 Unibio Recent Developments
- 4.7 Arbiom
- 4.7.1 Arbiom Company Information
- 4.7.2 Arbiom Business Overview
- 4.7.3 Arbiom Engineered Bacterial Cell Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Arbiom Engineered Bacterial Cell Protein Product Portfolio
- 4.7.5 Arbiom Recent Developments
- 4.8 NovoNutrients
- 4.8.1 NovoNutrients Company Information
- 4.8.2 NovoNutrients Business Overview
- 4.8.3 NovoNutrients Engineered Bacterial Cell Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 NovoNutrients Engineered Bacterial Cell Protein Product Portfolio
- 4.8.5 NovoNutrients Recent Developments
- 4.9 Superbrewed Food
- 4.9.1 Superbrewed Food Company Information
- 4.9.2 Superbrewed Food Business Overview
- 4.9.3 Superbrewed Food Engineered Bacterial Cell Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Superbrewed Food Engineered Bacterial Cell Protein Product Portfolio
- 4.9.5 Superbrewed Food Recent Developments
- 4.10 Solar Foods
- 4.10.1 Solar Foods Company Information
- 4.10.2 Solar Foods Business Overview
- 4.10.3 Solar Foods Engineered Bacterial Cell Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Solar Foods Engineered Bacterial Cell Protein Product Portfolio
- 4.10.5 Solar Foods Recent Developments
- 4.11 Bond Pet Foods
- 4.11.1 Bond Pet Foods Company Information
- 4.11.2 Bond Pet Foods Business Overview
- 4.11.3 Bond Pet Foods Engineered Bacterial Cell Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bond Pet Foods Engineered Bacterial Cell Protein Product Portfolio
- 4.11.5 Bond Pet Foods Recent Developments
5 Global Engineered Bacterial Cell Protein Market Scenario by Region
- 5.1 Global Engineered Bacterial Cell Protein Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Engineered Bacterial Cell Protein Sales by Region: 2021-2032
- 5.2.1 Global Engineered Bacterial Cell Protein Sales by Region: 2021-2026
- 5.2.2 Global Engineered Bacterial Cell Protein Sales by Region: 2027-2032
- 5.3 Global Engineered Bacterial Cell Protein Revenue by Region: 2021-2032
- 5.3.1 Global Engineered Bacterial Cell Protein Revenue by Region: 2021-2026
- 5.3.2 Global Engineered Bacterial Cell Protein Revenue by Region: 2027-2032
- 5.4 North America Engineered Bacterial Cell Protein Market Facts & Figures by Country
- 5.4.1 North America Engineered Bacterial Cell Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Engineered Bacterial Cell Protein Sales by Country (2021-2032)
- 5.4.3 North America Engineered Bacterial Cell Protein Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Engineered Bacterial Cell Protein Market Facts & Figures by Country
- 5.5.1 Europe Engineered Bacterial Cell Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Engineered Bacterial Cell Protein Sales by Country (2021-2032)
- 5.5.3 Europe Engineered Bacterial Cell Protein Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Engineered Bacterial Cell Protein Market Facts & Figures by Country
- 5.6.1 Asia Pacific Engineered Bacterial Cell Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Engineered Bacterial Cell Protein Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Engineered Bacterial Cell Protein Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Engineered Bacterial Cell Protein Market Facts & Figures by Country
- 5.7.1 South America Engineered Bacterial Cell Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Engineered Bacterial Cell Protein Sales by Country (2021-2032)
- 5.7.3 South America Engineered Bacterial Cell Protein Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Engineered Bacterial Cell Protein Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Engineered Bacterial Cell Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Engineered Bacterial Cell Protein Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Engineered Bacterial Cell Protein Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Engineered Bacterial Cell Protein Sales by Type (2021-2032)
- 6.1.1 Global Engineered Bacterial Cell Protein Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Engineered Bacterial Cell Protein Sales Market Share by Type (2021-2032)
- 6.2 Global Engineered Bacterial Cell Protein Revenue by Type (2021-2032)
- 6.2.1 Global Engineered Bacterial Cell Protein Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Engineered Bacterial Cell Protein Revenue Market Share by Type (2021-2032)
- 6.3 Global Engineered Bacterial Cell Protein Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Engineered Bacterial Cell Protein Sales by Application (2021-2032)
- 7.1.1 Global Engineered Bacterial Cell Protein Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Engineered Bacterial Cell Protein Sales Market Share by Application (2021-2032)
- 7.2 Global Engineered Bacterial Cell Protein Revenue by Application (2021-2032)
- 7.2.1 Global Engineered Bacterial Cell Protein Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Engineered Bacterial Cell Protein Revenue Market Share by Application (2021-2032)
- 7.3 Global Engineered Bacterial Cell Protein Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Engineered Bacterial Cell Protein Value Chain Analysis
- 8.1.1 Engineered Bacterial Cell Protein Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Engineered Bacterial Cell Protein Production Mode & Process
- 8.2 Engineered Bacterial Cell Protein Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Engineered Bacterial Cell Protein Distributors
- 8.2.3 Engineered Bacterial Cell Protein Customers
9 Global Engineered Bacterial Cell Protein Analyzing Market Dynamics
- 9.1 Engineered Bacterial Cell Protein Industry Trends
- 9.2 Engineered Bacterial Cell Protein Industry Drivers
- 9.3 Engineered Bacterial Cell Protein Industry Opportunities and Challenges
- 9.4 Engineered Bacterial Cell Protein Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst